Product Information
PANTOPRAZOLE SODIUM 40 MG VIAL is a generic product labeled by Piramal Critical Care, priced at $2.3740 per EA under NDC 66794025841. Its NADAC has been published 98 times since Nov 20, 2024.
FDA first approved this application on May 19, 2022. Its Orange Book therapeutic-equivalence code is AP.
Strength
40 mg/10mL
Manufacturer
Piramal Critical CareNDC
66794025841
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
3/18/2026
Active Ingredients
PANTOPRAZOLE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA214680FDA Approved
5/19/2022
TE Code
AP
On Market Since
10/10/2023
Pharmacological Classes
Price Statistics
The NADAC for PANTOPRAZOLE SODIUM 40 MG VIAL has been published 98 times since Nov 20, 2024, and over the history we have for it it has declined 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3740 per EA |
|---|---|
| All-time high | $2.4251 (Dec 11, 2024) |
| All-time low | $1.8514 (May 21, 2025) |
| 52-week high | $2.3740 |
| 52-week low | $1.8514 |
| Median price | $2.1907 |
| Average price | $2.1307 |
| Largest weekly change | +28.2% (Jan 21, 2026) |
| Weeks tracked | 98 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Piramal Critical Care manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PANTOPRAZOLE SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PANTOPRAZOLE SODIUM 40 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for PANTOPRAZOLE SODIUM 40 MG VIAL, manufactured by Piramal Critical Care, is $2.3740 per EA (NDC 66794025841), effective Sep 30, 2026.
How has the price of PANTOPRAZOLE SODIUM 40 MG VIAL changed over time?
Over the history we have for it, the NADAC for PANTOPRAZOLE SODIUM 40 MG VIAL has declined 2.1%. It has been tracked across 98 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for PANTOPRAZOLE SODIUM 40 MG VIAL?
Since Nov 20, 2024, the NADAC for PANTOPRAZOLE SODIUM 40 MG VIAL has ranged from a low of $1.8514 (May 21, 2025) to a high of $2.4251 (Dec 11, 2024), with a median of $2.1907 per EA.
Are there cheaper alternatives to PANTOPRAZOLE SODIUM 40 MG VIAL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PANTOPRAZOLE SODIUM 40 MG VIAL, is $1.8514 per EA — about 22% below PANTOPRAZOLE SODIUM 40 MG VIAL.
Who manufactures PANTOPRAZOLE SODIUM 40 MG VIAL?
PANTOPRAZOLE SODIUM 40 MG VIAL (NDC 66794025841) is labeled by Piramal Critical Care, and CMS classifies it as a generic product.